Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Why TPL and Alliasence need to be removed from control of MMP licensing

What's the likelihood of these being fulfilled before the patents expire?

"...the only path to success for a rising share price has been a three-step process. First, we have needed a judgment of infringement, which, though provisional at the moment, we now have. Second, we need to bring in big bucks, which is the subject of your post. And third, the money brought in must be used to create shareholder value --- supposedly, we have at least an informal commitment from the BoD to pay dividends if Step 2 comes to fruition."

Share
New Message
Please login to post a reply